Gene Therapies: The Pipeline Towards a New Era for Patients

10:45 AM - 11:40 AM, Tuesday, October 22, 2019 ・ 2nd Floor
Gene therapies have the potential to increase the healthspan of patients and offer new approaches to treating diseases, with a sizable pipeline in development. Early leaders in the field have focused on rare diseases which continues to open the pathway for other treatments in oncology and infectious and chronic diseases. Attend this session to hear about successful approaches, challenges in protein delivery, and the future of expanding this class of medicines.
Canaccord Genuity Inc.
Chief Scientific Officer
Senti Bio
President and CEO
CODA Biotherapeutics
Associate Director, Portfolio Development & Review
California Institute for Regenerative Medicine (CIRM)